In previous studies, miR-1 has been shown not only to target PIK3CA and inhibit the tumorigenic properties of lung cancer cells but also to be useful in predicting lymph node metastasis and postoperative recurrence in patients with NSCLC [36, 37]. This evidence concerns the gene PIK3CA and metastatic malignant neoplasm in the lymph nodes.